Owlet reschedules Vargas v. Workman settlement hearing to February 25

Digital health company Owlet, Inc. (NYSE: OWLT) announced in a Form 8-K filing on February 5, 2026, that a federal court has rescheduled the settlement hearing for the legal action Vargas v. Workman. The hearing, originally slated to take place on February 6, will now be held on February 25, 2026, at the U.S. District Court for the Central District of California. This delay was formalized through a revised Notice of Pendency of Settlement of Action, which the company submitted to satisfy judicial requirements for public disclosure during the settlement process. The rescheduling of this hearing comes amid a period of significant operational expansion for the infant monitoring company. Owlet has recently prioritized its technology integration by forming a strategic partnership with webAI to incorporate secure, personalized artificial intelligence into its product line. This initiative is designed to provide families with more granular health insights while ensuring that sensitive data remains private, a move that aligns with the company's broader objective to transition from consumer electronics into the regulated medical device space. In addition to its software advancements, Owlet has aggressively expanded its market reach through new distribution channels and subscription models. The company recently increased the accessibility of its FDA-cleared BabySat pulse oximeter through a partnership with 1 Natural Way, enabling insurance coverage via Medicaid and TRICARE. Furthermore, the launch of the Owlet360 service in the United Kingdom and Ireland reflects a shift toward recurring revenue streams. Financial analysts have responded positively to these developments, with firms like TD Cowen and William Blair issuing favorable ratings based on the company's growth trajectory in pediatric health monitoring.